Discontinued — last reported Q2 '19
Humana Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) increased by 212.7% to $7.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.3%, from $5.59B to $7.29B. Over 3 years (FY 2022 to FY 2025), Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) shows a downward trend with a -19.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests short-term market pressure on the bond portfolio, potentially due to rising interest rates or credit spread widening.
This metric tracks the fair value of debt securities classified as available-for-sale that have been in an unrealized lo...
Commonly disclosed by large financial institutions under ASC 320/326 accounting standards.
afs_debt_securities_unrealized_loss_less_than_12m| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.42B | $3.68B | $4.99B | $3.62B | $4.70B | $4.34B | $1.55B | $7.20B | $5.59B | $4.62B | $2.99B | $2.33B | $7.29B |
| QoQ Change | — | -16.7% | +35.6% | -27.4% | +29.9% | -7.7% | -64.3% | +364.7% | -22.3% | -17.5% | -35.3% | -22.0% | +212.7% |
| YoY Change | — | — | — | -18.1% | +27.8% | -13.0% | — | +98.8% | +18.9% | +6.4% | +92.9% | -67.6% | +30.3% |